These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 8035327)

  • 1. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
    Rothman RB; Cadet JL; Akunne HC; Silverthorn ML; Baumann MH; Carroll FI; Rice KC; de Costa BR; Partilla JS; Wang JB
    J Pharmacol Exp Ther; 1994 Jul; 270(1):296-309. PubMed ID: 8035327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of the biogenic amine transporters. VI. Characterization of a novel cocaine binding site, identified with [125I]RTI-55, in membranes prepared from whole rat brain minus caudate.
    Rothman RB; Silverthorn ML; Baumann MH; Goodman CB; Cadet JL; Matecka D; Rice KC; Carroll FI; Wang JB; Uhl GR
    J Pharmacol Exp Ther; 1995 Jul; 274(1):385-95. PubMed ID: 7616423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of the biogenic amine transporters. V. Demonstration of two binding sites for the cocaine analog [125I]RTI-55 associated with the 5-HT transporter in rat brain membranes.
    Silverthorn ML; Dersch CM; Baumann MH; Cadet JL; Partilla JS; Rice KC; Carroll FI; Becketts KM; Brockington A; Rothman RB
    J Pharmacol Exp Ther; 1995 Apr; 273(1):213-22. PubMed ID: 7714769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of the biogenic amine transporters. VII. Characterization of a novel cocaine binding site identified with [125I]RTI-55 in membranes prepared from human, monkey and guinea pig caudate.
    Rothman RB; Silverthorn ML; Glowa JR; Matecka D; Rice KC; Carroll FI; Partilla JS; Uhl GR; Vandenbergh DJ; Dersch CM
    Synapse; 1998 Apr; 28(4):322-38. PubMed ID: 9517841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping dopamine transporters in the human brain with novel selective cocaine analog [125I]RTI-121.
    Staley JK; Boja JW; Carroll FI; Seltzman HH; Wyrick CD; Lewin AH; Abraham P; Mash DC
    Synapse; 1995 Dec; 21(4):364-72. PubMed ID: 8869167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain.
    Boja JW; Mitchell WM; Patel A; Kopajtic TA; Carroll FI; Lewin AH; Abraham P; Kuhar MJ
    Synapse; 1992 Sep; 12(1):27-36. PubMed ID: 1411961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the biogenic amine transporters. III. Demonstration of two binding sites for [3H]GBR12935 and [3H]BTCP in rat caudate membranes.
    Akunne HC; Dersch CM; Cadet JL; Baumann MH; Char GU; Partilla JS; de Costa BR; Rice KC; Carroll FI; Rothman RB
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1462-75. PubMed ID: 7908058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout mice.
    Rothman RB; Carroll FI; Morales M; Rowley DL; Rice KC; Dersch CM; Donovan DM
    Synapse; 2002 May; 44(2):94-105. PubMed ID: 11891881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [125I]RTI-55 binding to cocaine-sensitive dopaminergic and serotonergic uptake sites in the human brain.
    Little KY; Kirkman JA; Carroll FI; Breese GR; Duncan GE
    J Neurochem; 1993 Dec; 61(6):1996-2006. PubMed ID: 8245956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
    Rothman RB; Dersch CM; Carroll FI; Ananthan S
    Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective labeling of the dopamine transporter by the high affinity ligand 3 beta-(4-[125I]iodophenyl)tropane-2 beta-carboxylic acid isopropyl ester.
    Boja JW; Cadet JL; Kopajtic TA; Lever J; Seltzman HH; Wyrick CD; Lewin AH; Abraham P; Carroll FI
    Mol Pharmacol; 1995 Apr; 47(4):779-86. PubMed ID: 7723739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualizing dopamine and serotonin transporters in the human brain with the potent cocaine analogue [125I]RTI-55: in vitro binding and autoradiographic characterization.
    Staley JK; Basile M; Flynn DD; Mash DC
    J Neurochem; 1994 Feb; 62(2):549-56. PubMed ID: 8294917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of [125I]RTI-55 binding to dog caudate dopamine transporter.
    Patel A
    Neuroreport; 1993 Nov; 5(2):157-60. PubMed ID: 8111003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.
    Eshleman AJ; Carmolli M; Cumbay M; Martens CR; Neve KA; Janowsky A
    J Pharmacol Exp Ther; 1999 May; 289(2):877-85. PubMed ID: 10215666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IPT: a novel iodinated ligand for the CNS dopamine transporter.
    Kung MP; Essman WD; Frederick D; Meegalla S; Goodman M; Mu M; Lucki I; Kung HF
    Synapse; 1995 Aug; 20(4):316-24. PubMed ID: 7482291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between [125I]RTI-55-labeled cocaine binding sites and the serotonin transporter in rat placenta.
    Shearman LP; McReynolds AM; Zhou FC; Meyer JS
    Am J Physiol; 1998 Dec; 275(6):C1621-9. PubMed ID: 9843724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug interactions with the dopamine transporter in cryopreserved human caudate.
    Eshleman AJ; Wolfrum K; Mash DC; Christensen K; Janowsky A
    J Pharmacol Exp Ther; 2001 Feb; 296(2):442-9. PubMed ID: 11160629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the biogenic amine transporters. XI. Identification of a 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR12909) analog that allosterically modulates the serotonin transporter.
    Nightingale B; Dersch CM; Boos TL; Greiner E; Calhoun WJ; Jacobson AE; Rice KC; Rothman RB
    J Pharmacol Exp Ther; 2005 Aug; 314(2):906-15. PubMed ID: 15860577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding.
    Wall SC; Innis RB; Rudnick G
    Mol Pharmacol; 1993 Feb; 43(2):264-70. PubMed ID: 8429827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methyl 3 beta-(4-[125I]iodophenyl)tropane-2 beta-carboxylate in vitro binding to dopamine and serotonin transporters under "physiological" conditions.
    Laruelle M; Giddings SS; Zea-Ponce Y; Charney DS; Neumeyer JL; Baldwin RM; Innis RB
    J Neurochem; 1994 Mar; 62(3):978-86. PubMed ID: 8113817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.